clinical trial · NCT04784533
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Alopecia AreataCTP-543Placebo
brief summary
This study is designed to evaluate the regrowth of hair with CTP-543 and subsequent durability of that regrowth following dose reduction in adult patients with moderate to severe alopecia areata.
started
Feb 26, 2021
primary completion
May 16, 2023
completion
May 16, 2023
last updated
Oct 9, 2024
official title
A Study to Evaluate Maintenance of Hair Regrowth Following Dose Reduction of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol